GL392
GL392 is a targeted senolytic prodrug that delivers Dasatinib specifically to senescent cells via lipofuscin binding, inducing apoptosis. Encapsulated in PEO-b-PCL microcapsules for efficient delivery, it is used in cancer research and studies of aging-related diseases for both in vitro and in vivo senolysis.
Product Specifications
Field of Research
Cell Biology
Smiles
O=C (CCC (OCCN1CCN (C2=CC (NC3=NC=C (C (NC4=C (C=CC=C4Cl) C) =O) S3) =NC (C) =N2) CC1) =O) OCC (N5) (C) NC6=CC=CC (C6=C5C=C7) =C7/N=N/C (C=C8) =C9C (C=CC=C9) =C8/N=N/C%10=CC=CC=C%10
Molecular Formula
C55H52ClN13O5S
Molecular Weight
1042.6
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
VAng-Cr5326-50gEcoli 50 µg (E. coli)
Recombinant Klebsiella Pneumoniae rplD Protein (aa 1-201) (strain ATCC 700721 / MGH 78578)
Sign In for Pricing
View Details 